DOJ Charged Providers in Healthcare Fraud Takedown
Federal authorities charged 455 defendants in a massive June 2026 scheme involving skin-substitute billing fraud.
Updated on Sept. 23, 2026 in Financial Crime
Live Poll
Do you believe federal oversight is currently effective at preventing healthcare billing fraud in the U.S.?
On June 23, 2026, the Department of Justice announced a massive healthcare fraud takedown involving 455 defendants across the United States. The enforcement actions centered on wound-care providers who allegedly submitted inflated invoices for skin substitutes to Medicare.
Why it matters
The government launched these actions to address financial incentives created when Medicare reimbursement rates for skin substitutes exceeded actual purchase prices. This disparity led to Medicare spending surging from $256 million in 2019 to over $14 billion by 2025.
The government brought False Claims Act enforcement against hundreds of defendants, including the United States v. McMillan and United States v. Cherny cases. These investigations currently involve allegations of $268 million in payments and $94 million in kickbacks.
The players
Department of Justice
This federal executive department is responsible for the enforcement of laws and the administration of justice in the United States.
HHS-OIG
The Office of Inspector General protects the integrity of Department of Health and Human Services programs by investigating fraud and abuse.
The details
Data analytics teams identified enforcement targets by detecting irregular payment spikes for skin-substitute products. Providers in these cases allegedly inflated purchase price information to secure higher reimbursements than the actual product costs.
Timeline
Medicare spending on skin substitutes totaled $256 million in 2019.
HHS-OIG identified reimbursement concerns in September 2025.
A flat reimbursement rate of $127.14 per square centimeter began January 1, 2026.
The DOJ announced the 2026 National Health Care Fraud Takedown on June 23, 2026.
Legal Context
These prosecutions utilize the False Claims Act to address systemic billing exploitation within the federal healthcare system. This enforcement reflects a broader trend of using advanced data analytics to identify and penalize large-scale healthcare fraud.
The government's crackdown aims to stabilize Medicare expenditures by eliminating fraudulent billing incentives for wound-care providers. These actions reflect ongoing efforts to prevent the inflation of healthcare costs that impact the broader Medicare program.
The takeaway
The implementation of a flat national reimbursement rate of $127.14 per square centimeter is expected to curtail future Medicare spending on skin substitutes. These legal actions highlight how federal agencies are increasingly relying on data analytics to detect and prosecute billing irregularities.
Further reading
For more on the crackdown against complex financial abuses, visit Financial Crime.
Source note: This article includes information reported by The National Law Review - A Free To Use Nationwide Database of Legal Publications.
Live Poll
Do you believe federal oversight is currently effective at preventing healthcare billing fraud in the U.S.?
